Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Canestrini

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Minerva Dietologica E Gastroenterologica|April 1, 1989
[Mid-term natural course in Naples of chronic HBeAg positive infection caused by the HB-virus. Prospective study, preliminary to antiviral treatment]C Canestrini, L Amitrano, A Ascione, et al.
Hepato-Gastroenterology|June 1, 1984
Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it?A Ascione, L Amitrano, E Riccio, et al.
Neuropediatrics|December 19, 2009
Epilepsy in patients with propionic acidemiaE Haberlandt, C Canestrini, M Brunner-Krainz, et al.
Minerva Gastroenterologica E Dietologica|July 1, 1991
[Prevalence of antibody to hepatitis C virus in hospital personnel]M De Luca, A Ascione, C Canestrini, et al.
Italian Journal of Gastroenterology and Hepatology|December 4, 1998
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre studyA Ascione, M De Luca, C Canestrini, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Minerva Dietologica E Gastroenterologica|April 1, 1989
[Mid-term natural course in Naples of chronic HBeAg positive infection caused by the HB-virus. Prospective study, preliminary to antiviral treatment]C Canestrini, L Amitrano, A Ascione, et al.
Hepato-Gastroenterology|June 1, 1984
Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it?A Ascione, L Amitrano, E Riccio, et al.
Neuropediatrics|December 19, 2009
Epilepsy in patients with propionic acidemiaE Haberlandt, C Canestrini, M Brunner-Krainz, et al.
Minerva Gastroenterologica E Dietologica|July 1, 1991
[Prevalence of antibody to hepatitis C virus in hospital personnel]M De Luca, A Ascione, C Canestrini, et al.
Italian Journal of Gastroenterology and Hepatology|December 4, 1998
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre studyA Ascione, M De Luca, C Canestrini, et al.
Pageof 2